Risk Stratification for Arrhythmic Events in Postinfarction Patients
The value of heart rate variability, ambulatory electrocardiographic (ECG) variables and the signal-averaged ECG in the prediction of arrhythmic events (sudden death or life-threatening ventricular arrhythmia,) was assessed before hospital discharge in 416 consecutive survivors of acute myocardial infarction . During the follow-up period (range I to 1,112 days), there were 24 arrhythmic events and 47 deaths . The initial relation between several prognostic factors and arrhythmic events was explored with use of the Kaplan-Meier product limit estimates of survival function.
Impaired heart rate variability <20 ms (p < 0 .0000), late potentials (p < 0 .0000), ventricular ectopic beat frequency (p < 0.0000), repetitive ventricular forms (p < 0 .0000), left ventricular ejection fraction <40% (p < 0.02) and Killip class (p < 0 .02) were Identified as significant univariate predictors of arrhythmic Many cases of sudden death after myocardial infarction are thought to result from ventricular tachyarrhythmias (1) . Previous attempts to identify on the basis of ambulatory electrocardiographic (ECG) monitoring, left ventricular r. cnction and exercise testing those patients who will experience sudden death have proved disappointing and have not led to effective methods of risk stratification or treatment strategies . Programmed ventricular stimulation may be an accurate predictor of arrhythmic death, but it is invasive and considerable debate remains regarding the selecliun of patients and stimulation protocols (2) . Recently, several studies have reported that impaired heart rate variability (an index of parasympathetic function) (3) or an abnormal signalaveraged high resolution ECG (4) may be of prognostic value in survivors of myocardial infarction . Abnormal autonomic function is known to predispose to arrhythmogenesis in both clinical and experimental situations (5, 6) , whereas the pres- 11991 by the American College of C,rdiolo6y 687 events . When these variables were analyzed by using a stepwise Cox regression model, only impaired heart rate variability, fol . lowed by late potentials and repetitive ventricular forms remained independent predictors of arrhythmic events. The combination of impaired heart rate variability and late potentials had a sensitivity of 58%, a positive predictive accuracy of 339 and a relative risk of 18.5 for arrhythmic events and was superior to other combinations including those incorporating left ventricular function, exercise ECG, ventricular ectopic beat frequency and repetitive ventricular forms .
These results suggest that a simple method of assessment based on heart rate variability and the signal-averaged ECG ran select a small subgroup of survivors of myocardial infarction at high risk of future life-threatening arrhythmias and sudden death .
(3 Am Coil Cordial 1991 ;18.607-97) race of late potentials on the signal-averaged ECG or frequent or repetitive ventricular ectopic beats are said to" markers of the anatomic substrate for ventricular tachyarrhythmias (7) (8) (9) . Unfortunately, the positive predictive accuracy of late potentials alone for arrhythmic events is low . The aim of this study was to investigate the prognostic value of heart rate variability in combination with ambulatory ECG (Hotter) data or late potentials with the anticipation that the combination of abnormal autonomic tone and arrhythmogenic substrate might result in a powerful predictor of arrhythmic events . Recent advances in Holter technology may make it possible to derive heart rate variability and late potential data from a single ECG recording in addition to traditional variables such as ventricular ectopic beat frequency end repetitiveness .
Methods
Study patients. Over a period of 3 years, 487 consecutive patients <70 years of age were admitted to St . George's Hospital with a confirmed diagnosis of acute myocardial infarction. Each patient underwent a standard assessment, including the recording of historical and clinical data on PARRFLLET AL PRE IIICTI (IN (IF ARRHYTHMIC EVENTS admission and in-hospital complications . A standard risk stratification protocol was performed before hospital discharge at day 5 to 7; it included a predischarge exercise ECG test . a signal-averaged ECG recording and 24-h Holler monitor analysis for ventricular cclopic beat frequency, ventricular arrhythmias and heart rate variability . Those patients with a positive exercise test underwent cardiac catheterization before discharge, whereas those patients with a negative test underwent radionuclide-gated blood pool scanning to assess left ventricular ejection fraction .
Assessment of heart rate variability . All patients in sinus rhythm underwent heart rate variability analysis from 24-h ECG recordings taken on day 6 or 7 after infarction . Heart rate variability was calculated by a previously described method (10) . The frequency distribution of durations of normal to normal RR intervals was constructed and heart rate variability was expressed as the baseline width of the distribution curve measured by the method of least square difference interpolation. In each recording, the mean duration of normal RR intervals was also computed . The previously described method of expressing heart rate variability as the standard deviation of normal RR intervals was not used because the computer system of analysis is known to be affected by recording noise and misrecognition artifact. The method of triangular interpolation of the frequency distribution of RR interval duration is not affected by low levels of noise and artifact (Ill . A fuller description and diagram concerning the calculation of heart rate variability are presented in the Appendix . All recordings were made with patients taking no antiarrhythmic treatment and, where possible, without beta-adrenergic blocking therapy . In 26 patients, beta-blacker administration could not be stopped before study .
Assessment of signal-averaged ECC . This was recorded using a commercially available system (Arrhythmia Research Technology, model 1200EPX) . The method used has been described elsewhere (12) . The high pass filter was set at 25 Hz and 100 to 200 beats were averaged to achieve a noise level <0 .4 yvV . Recordings were made on day 6 or 7 in all patients with sinus rhythm . Late potentials were considered to be present if any two of the following criteria were present : filtered QRS complex >120 ms, root-mean-squ.,re voltage during the last 40 ms of the filtered QRS complex <25 yaV and duration of the filtered QRS complex <40 ms after voltage decreased to <40 yaV, Conventional risk stratification methods. Clinical and historical data were recorded, including Killip class on admission . Hotter tapes were analyzed for both ventricular ectopic beat frequency and for ventricular repetitive forms (couplets or nonsustained ventricular tachycardia A previous pilot study performed in our department showed a strong correlation between ejection fraction calculated by these two methods (r = 0 .91). Where possible, the number of diseased coronary arteries (>50% stenosis) was recorded as well as infarctrelated artery patency (Thrombolysis in Myocardial Infarction [TIMI] grade 2). All in-hospital treatment and drug treatment on discharge were recorded . After discharge, no limitations were placed on the supervising physicians in their use of drugs (including beta-blockers), although there was no routine use of antiarrhythmic drugs.
Exclusion criteria . Those patients not in sinus rhythm were excluded from analysis of heart rate variability and the signal-averaged ECG . Patients with severe life-thr-atening concomitant diseases such as carcinoma, which may have influenced survival data, were excluded. Patients living remote from the hospital were also excluded because of difficulties in follow-up. The characteristics of the 71 patients who were excluded are given in Table 1 .
Study patients and treatment (Table 1) . Four hundred sixteen patients from the total group of 487 were assessed for heart rate variability and late potentials . The study group was predominantly male with a mean age of 57 .1 ± 9.3 years, In 53 .7% of patients the infarct site was inferoposterior ; a Q wave infarction was present in 62 .8% and the mean left ventricular ejection fraction was 50 .1 ± 14.7%. Thrombolytic therapy was received by 48% of patients at admission and a beta-blocker was prescribed at discharge in 39% . Twenty-four percent of patients underwent revascularization (angioplasty or coronary vein grafting) . Except for the use of thrombolytic and beta-blocker therapy there was little difference between the study and excluded groups ( ice the relation between heart rate variability and continuous variables such as age and left ventricular function . Student's t test and chi-square analysis with Yaics' correction were used where appropriate and statistical significance was assumed for p values < 0 .05. The onivariate relation among arrhythmic events. mortality, prognostic indicators such as heart rate variability and the signal-averaged ECG was initially explored by using the Kaplan-Meier product limit estimates of the survival function and the log-rank test. The Cox proportional hazards scrvival model was used to calculate the relative risk with use of betas (regression coefficients). Multivariate analysis was also performed by using the Cox stepwise proportional hazards model to assess the independence of the association between prognostic variables, arrhythmic events and mortality .
On the basis of a prior pilot study heart rate variability was dichotomized at levels of 20 and 16 ms (mean . I SDI . Dichotomy points for ventricular ectopic beat frequency >101h, left ventricular ejection fraction <40% and age >65 years were based on previous reports from the Multicenter Postinfarction Research Group (9) . As in the study of Kleiger et al. (3), heart rate (expressed as the mean RR interval over 24 h) was dichotomized at a level of 750 ms.
Major end points analyzed mere I) arrhythmic events, and 2) all-cause cardiac mortality . Arrhythmic events included all patients who presented again after discharge with sustained ventricular tachyarrhythmia or arrhythmic death . Arrhythmic death was defined according to the Cardiac Arrhythmias Pilot Study (CAPS) definition (13) . In the past, arrhythmic or sudden death was classified on a temporal basis, usually within I h of the onset of symptoms and this has proved to be very inaccurate. The CAPS definition takes account of the clinical setting and prior symptoms and thus death within I h of symptoms or during sleep was classified as arrhythmic, provided it did not occur in a setting of increasing angina or overt heart failure .
Results
Heart rate variability . The mean heart rate variability for the total group of 416 patients was 27 . 10 .9 ms (range 3 .2 to 80 .9) . Heart rate variability was <20 ms in 113 patients and <16 ms in 59 additional patients . Significant but weak correlations were noted between heart rate variability and both left ventricular ejection fraction (r== 0 .091, p < 0 .0001) and mean RR interval Ict = 0 .31, p < 0.0004 . Heart rate variability was also weakly correlated inversely with age (r' = 0.05, p < 0.0001) (Fig . 11 . The relations among heart rate variability. left ventricular ejection fraction and other prognostic variables is illustrated in Figure 2 . Heart rate variability was similar in those patients with inferoposterior or anterior infarction (26.7 . 10.9 vs . 26 .9 `_ 11 .2 ms), but patients with Q wave infarction did have significantly reduced heart rate variability (25 .4 > 10 .7 vs . 29.6 '_ 11 .2 ms . p < 0 .001) . Heart rate variability was also significantly reduced in patients with markers of arrhythmic propensity . such as ventricular ectopic heat frequency. late potentials and impaired left ventricular ejection fraction (<40%e) . but not in patients with a positive exercise test . In the 231 patients who underwent cardiac catheterization . heart rate variability was not related to the number of diseased coronary arteries (single-vessel disease 28 .9 ± 11 .1 ms, doublevessel disease 26.6 > 11 .2 ms and triple-vessel disease 28 .7 . 10 .3 ms) or infarct-related artery patency (28 .7 ± 9.7 vs. 28 ± 11 .3 ms) .
Late potentials. Eighty-nine patients had positive late potentials on the signal-averaged ECG . Patients with reduced heart rate variability (<20 ms) had a significantly higher incidence of late potentials (36. Conventional stratification . In 210 patients, the exercise ECG was considered positive . Left ventricular ejection fraction was <40% in 110 patients and 83 patients were classified in Killip class >2 at admission .
Follow-up data and events . The mean follow-up period was 612 days (range I to 1, 112). During this period, there were 24 arrhythmic events . Forty-seven patients died from cardiac causes and there were 40 documented cases of reinfarction . In the 71 patients excluded from the study (because of atrial fibrillation or technical or administrative problems), there were 14 deaths, 9 arrhythmic events and 7 reinfarctions .
Heart rate variability, late potentials, ambulatory ECG variables and arrhythmic events . In those patients who had an arrhythmic event after discharge, heart rate variability was markedly reduced (16 .4 ± 7 .9 vs . 27.7 t 10.8 ms, p < 0 .0001). It is also of interest to note that heart rate variability was lower in patients who had primary ventricular fibrillation on admission (22 .1 t 8 .51 vs. 27 .4 ± 11 ms, p < 0.003) (Fig . 3) . When all-cause cardiac mortality is considered, heart rate variability was again markedly lower (20 .5 t 12.5 vs. 27 .8 ± 10 .5 ms, p < 0.0001) . Patients with reinfarction (fatal or nonfatal) had no significant difference in heart rate variability (30.2 ± 11 .2 vs . 26 .6 ± 10 .9 ms, p = 0 .06). Late potentials were more prevalent in patients with an arrhythmic event (66 .7% vs. 18 .6%, p < 0.0001) and cardiac death (36 Figure 3 , Plot of heart rate variability (HRV) according to clinical events. VF = ventricular fibrillation occurring within the Ist 24 h after infarction, 22.3%, p = NS). Repetitive ventricular forms were also more frequent in patients with an arrhythmic event (54% vs . 18%, p = 0 .0002) and death (36% vs. 197%, p = 0.0008) . Similar findings were also noted for ventricular ectopic beat frequency and patients with an arrhythmic event (54% vs. 18%, p = 0 .0001) or death (40% vs . 18%, p = 0 .0002).
Survival analysis was performed for individual variables, combinations of variables, arrhythmic events and mortality by using the Kaplan-Meier product estimates of the survival function (log-rank) and the relative risks were then calculated by using the Cox proportional hazards survival model . The results for each variable and combination are presented for arrhythmic events (Table 2 ) and cardiac mortality (Table  3 ) . Figure 4 shows the Kaplan-Meier survivorship curves for arrhythmic events and cardiac mortality with the heart rate variability index stratified at >20, 16 to 19 and <16 ms . It can be seen from the survivorship curves that there are significant differences in the incidence of arrhythmic events and death in patients with heart rate variability dichotomized at 20 ms (p = 0 .0001 in both cases). Reducing the dichotomy level to 16 ms produced no further improvement in sensitivity because the arrhythmic event rates for patients with heart rate variability 16 to 19 ms and <16 ms were almost identical . The majority of arrhythmic events occurred early within the first few weeks and months after infarction . Of all variables analyzed, including impaired ventricular function, Hotter ambulatory ECG data and the signal-averaged ECG, impaired heart rate variability had the strongest association with both arrhythmic events and cardiac mortality .
Multivariate analysis. A stepwise Cox regression analysis was performed for the prediction of arrhythmic events and mortality using heart rate variability <20 ms, left ventricular ejection fraction <40%, Killip class >2, mean RR interval <750 ms, ventricular ectopic beats >IOlh, late potentials, repetitive ventricular forms, positive exercise ECG, Q wave, anterior infarction or age >65 years . In the prediction of arrhythmic events, heart rate variability <20 ms was se- Table 2 . Ranked Univariate Relation of Variables to .Arrhythmic Events in 416 Patients lected at step I (beta = 3 .457, ,tz = 21-89, p < 0 .0000), followed by the presence of late potentials at step 2 (beta = 1 .54, ,' = 14 .1, p < 0 .0002) and repetitive ventricular forms at step 3 (beta = 1 .273, ,° = 8 .93, p < 0 .003) . All other variables including left ventricular ejection fraction, heart rate and exercise testing were excluded . When all-cause mortality was considered, heart rate variability <20 ms was selected at step I (beta = 1 .64, = 26 .1, p < 0 .0000), followed by Killip class ?2 (beta = 1 .25, ,t% = 16 .5, p = 0.0002) and repetitive ventricular forms (beta = 0 .68 . X = 4.9, p = 0.03) .
Predictive accuracy of prognostic variables for arrhythmic events (Tables 4 to 6 ) . Impaired heart rate variability (<20 ms) was the most sensitive predictor of arrhythmic events (91 .6%) (Table 4) . Unfortunately, its specificity was sufficiently low (76 .8%) to result in a large number of false positive results and a low positive predictive accuracy (17%). Table 5 shows the value of heart rate variability combined with the signal-averaged ECG and other ambula-FARRELL ET AL . 691 PREDICTION OF ARRHYTHMIC EVENTS Exercise testing, age >65 years, site of infarction or Q wa infarction had no univariate relation to arrhythmic events. The initial relation between variables and anhylhmic events is expressed as she Kaplan-Meier product estimate of the survival function (log-rack) multivariate analysis ; the relative risk is calculated from the Cox analysis . C I =confidence interval .
tory ECG data contrasted to those based on ventricular function, including the left ventricular ejection fraction/ frequent ventricular ectopic beats C>1011)/fate potentials index described by Gomes et al. (14) . Of all the combinations, heart rate variability and late potentials were the most sensitive predictor of arrhythmic events (58%) with a relative risk of 18.5, followed by the heart rate variability/ repetitive forms with a sensitivity of 50% and a relative risk of 15 .0 (Table 6 ) . With use of such combinations, it is possible to identify a small subgroup of patients (-10% of the study group) in whom there will be a high incidence of events . Combined indexes using left ventricular ejection fraction rather than heart rate variability were markedly inferior (Tables 5 and 6 ) . The event curves for heart rate variability combined with late potentials for arrhythmic events and mortality are shown in Figure 5 .
Effects of treatment. The use of thrombolytic therapy did not effect heart rate variability (26.7 . 10.9 vs. 27 .3 11 .7 ms), left ventricular ejection fraction (50 .5 ± 14.2% vs. Years Figure 4 . Kaplan-Meier survivorship curves for arrhythmic events (top) and cardiac mortality (bottom). Heart rate variability (HRV) is stratified at >19, 16 to 19 and <16 ms. The p values refer to differences in event rates between subgroups (log-rank analysis) . PROB = probability.
49.6 ± 15 .3%) or the presence of late potentials (22% vs . 20.9%), frequent ventricular ectopic beats (15% vs . 16%) or repetitive ventricular forms (20% vs . 21%) . The incidence of death was significantly lower in patients receiving thrombolytic therapy (7 .5% vs . 14 .8%, p = 0 .028) and although the incidence of arrhythmic events was lower, this did not reach statistical significance (3 .5% vs. 8.3%, p = NS) . Significant differences existed between heart rate variability and left ventricular ejection fraction according to the use of a betablocker in patients . Among the 119 patients who received in-hospital beta-blocker therapy (started within 24 h of admission), heart rate variability was greater (29.6 '-9.8 vs .
26 ± 11 .2 ms, p = 0.001), but as might be expected these patients were younger and had better left ventricular function (ejection fraction 54 .3 ± 13 .8% vs . 48.4 ± 14.8%, p = 0.0001) and these differences most likely represent patient selection rather than an effect of beta-blockade . The incidence of late potentials was not significantly lower in patients who received in-hospital beta-blocker therapy (15 .8% vs . 23 .6%, p = NS) than in those discharged on beta-blocker therapy (11 .7% vs. 27 .6%, p = 0 .0002). When the use of these agents (streptokinase and beta-blackens) was added to the Cox proportional hazards analysis, the results were unchanged. suggesting that the prognostic value of heart rate variability and late potentials is independent of treatment .
Discussion
Criteria far risk stratification. Ideally, risk stratification should satisfy several criteria. Most important, it should identify patients at high risk and the specific mechanism by which death occurs and at which treatment can be aimed . Results should also be readily available before hospital discharge, allowing decisions regarding treatment and further investigation to be made in good time . From the survival curves presented in Figures 4 and 5 , it can be seen that the majority of arrhythmic events occur in the days or weeks immediately after discharge . As a consequence, many events will be missed by risk stratification schemes that are delayed (requiring patients to return for outpatient investigation) or whose results are not immediately available before discharge. Left ventricular function, which is the reference standard of risk stratification, does not appear to satisfy these criteria. In this study, it was not a powerful predictor of arrhythmic events ; impaired ventricular function (ejection fraction <40%) had a sensitivity of 46% and a positive predictive accuracy of only 10% . In marked contrast, impaired heart rate variability, either alone or in combination with late potentials on the signal-averaged ECG or repetitive ventricular forms, was a powerful predictor of mortality and a specific marker of arrhythmic events . Impaired ventricular function does not identify a specific mechanism by which patients will die; rather, a variety of reasons might be (12, 16) have suggested that patients with impaired ventricular function and frequent ventricular ectopic beats are at high risk of future mortality. However. the Cardiac Arrhythmia Suppression Trial (CAST) (17) has clouded the exact relevance of ventricular ectopic beat frequency in risk stratification and treatment, particularly because the risk of proarrhylhmia is greatest in those patients with poor ventricular function, leading to a marked imbalance in the benefits of treatment (18). In our study group, the combination of left ventricular ejection fraction and ventricular ectopic beat frequency was also inferior to the combination based on heart rate variability and repetitive ventricular forms . ectopic beat frequency or 'ate ECG potentials .
Is risk stratification with heart rate variability independent of heart rate or ventricular function? In our study heart rate and heart rate variability were weakly correlated, as might The initial rekulon haunts variable, and arrhythmic events i, expm,sed e, the Keplan-Meier product estimate of the --al fun n doe-rank) m .11-n-anak,is, the relative risk is calculated from the Cox analysis. Abbreviations a, in Tuhle, 2 end 5 . Figure 5 . Keplan-Meier survivorship curves for arrhythmic events (top) and cardiac mortality (bottom) in patients with depressed heart rate variability (HRV) <20 ms and positive (+ve) late potentials (LP) and ventricular ectepic beats . The p values refer to differences in event rates between subgroups (log-rank analysis). PROB = probability .
he expected because a pathologic process that shortens the RR interval will also reduce the absolute value of differences among RR intervals . This effect of heart rate on heart rate variability may he particularly pronounced if heart rate variability is calculated from short recordings of several minutes' duration rather than long-term recordings over 24 h . Several investigators, particularly those performing frequency domain analysis, which uses recordings of several minutes' duration, have normalized heart rate variability for the effects of heart rate, but this is not necessary if long-term recordings are used . We (19) recently compared the prognostic value of normalized heart rate variability (heart rate variability divided by the averaged RR interval) and crude heart rate variability in survivors of myocardial infarction . Normalized heart rate variability remained strongly associated with an increased risk of an arrhythmic event, confirming that heart rate variability carried prognostic information independent of heart rate, but we found its prognostic value to be less than that of crude heart rate variability, especially when long-term rather than short-term ECG recordings were used (19) . Therefore, from a clinical point of view, nonnormalized heart rate variability is preferable for prognostic studies . Kleiger et at . (3) also studied the relations among heart rate variability, heart rate and left ventricular ejection fraction and, even after patients had been IVEF M Ha ® HRV = HnV<HA Figure 6 . Receiver operator curves for heart rate variability (HRV) in combination with heart rate (HR) and left ventricular ejection fraction (LVEF).
stratified according to heart rate or left ventricular ejection fraction, reduced heart rate variability was independently associated with increased mortality. Multivariate analysis in our study revealed the association between heart rate variability, arrhythmic events and mortality to be independent of both heart rate and left ventricular ejection fraction. This is further illustrated in our Figure 6 , which shows the receiver operator curves for heart rate variability and various combinations of heart rate and left ventricular ejection fraction in the prediction of arrhythmic events . The theoretic methods involved in the construction of receiver operator curves is beyond the scope of this report and has been described elsewhere (20) , but rather than dichotomizing heart rate variability, heart rate and left ventricular ejection fraction at a specific point, they are considered as continuous variables, allowing multiple partitions. It can be seen that heart rate variability provides virtually all the predictive information and that the addition of the other variables such as heart rate and left ventricular ejection fraction adds little if any further information .
Why should autonomic function tests be of help in the prediction of arrhythmias? The heart receives a rich neural supply of both sympathetic and parasympathetic fibers and the electrical stability of the myocardium is dependent on the synergism between the two components . Parasympathetic discharge has a protective effect on ventricular fibrillation thresholds, whereas the deleterious effects of excessive sympathetic activity are well documented (21) (22) (23) . Work from our department (24) has demonstrated the importance of vagal reflexes in protecting survivors of infarction from the induction of ventricular arrhythmias at programmed ventricular stimulation, and several animal models (25, 26) of myocardial infarction and sudden death have stressed the protective function of vagally mediated reflex heart rate responses to acute isehemia . Animals with well preserved tACC V.I . IA, Nc. I Scplcmher199hva7-97 vagal reflexes were much less likely to develop ventricular fibrillation, Several mechanisms nmv account for the dismrbam e tf autonomic function after infarction . Areas of selective sympathetic and parasympathetic denervation may occur downstream from myocardial infarction (27,28), resulting in local supersensitivity to catecholamines and loss or alteration of afferent input to the higher neural centers. This may lead to an uncoupling of autonomic modulation, inappropriate sympathetic efferent discharge or loss of protective vagal reflexes (29) . Hemodynamic alterations after infarction may also be of importance because the upstroke velocity of systolic arterial pressure is an important determinant of carotid sinus nerve activity and, hence . the baroreceptor reflex (30) . Several groups (31, 32) have now documented a temporal depression of parasympathetic activity in the weeks immediately after infarction that is coincident with the period during which the risk of arrhythmic events is highest, and recent reports (3, 33) suggest that indexes of vagally mediated heart rate changes, such as heart rate variability or arterial baroreflex sensitivity, may be of particular value in postinfarction risk stratification .
Role of signal-averaged ECG . The presence of late potentials may indicate an "anatomic" substrate for reentrant ventricular tachyarrhythmias because these are thought to arise from areas of slow and inhomogeneous propagation of myocardial conduction . Their presence is independent of other Holler ECG variables such as ventricular ectopic beat frequency or repetitive forms (34), and several studies have reported late potentials to be better predictors of arrhythmic events than these Hotter variables . Prospective studies (4, 35) have suggested that in patients after infarction, late potentials are associated with a significantly higher arrhythmic event rate (range 17% to 24%) . but in general their prognostic value has been hindered by their low specificity . Games et al . (14) suggested that the predictive value of the signal-averaged ECG for arrhythmic events could be further increased to >50% by combination with an abnormal ejection fraction (<40%) and frequent ventricular ectopic beats ; the study group of Gomes et al . (14) had a very large number of patients with impaired ventricular function . In the present study, the combination of predictors used by Gomes et al . (14) had a sensitivity of only 20% and a positive predictive accuracy of 28%, which was markedly inferior to that of combinations based on heart rate variability, such as the heart rate variability, late potentials combination or heart rate variability with repetitive ventricular forms . Neither repetitive ventricular forms nor ventricular ectopic beat frequency was as strong a univariate marker of arrhythmic potential as were late potentials, and multivariate analysis selected only late potentials and repetitive ventricular forms in addition to impaired heart rate variability as independent predictors of arrhythmic events.
The results of this mtdtiruriate nnuNA, .suggest several possible risk stratification schemes The heart rate variability, late potentials combination, although not identifying all FARRFI 1 . FT AL . 695 VREDICTION OF ARRHYTHMIC EVENTS events, did select a small group (-I(j9 ofthe study group) in which there will be a high incidence of arrhythmic events (sensitivity 589/.-positive predictive accuracy 33% and a relative risk of 18.5). The combination of all three variables (heart rate variability . late potentials and repetitive forms) . although having an even higher predictive accuracy of 585?c and a relative risk of 23 .5 had a sensitivity of only 29' .'%%9 . In this study, heart rate variability and the signal-averaged ECG were recorded separately-but recent advances in Holier technology and signal processing may make it possible to gain this information solely from long-term ECG recording (16) . The combination of heart rate variability and late potentials as a method of risk stratification has a conceptual basis in that it identifies patients with a potential anatomic substrate for ventricular tachyarrhythmias in whom the presence of abnormal autonomic tone may permit the genesis of ventricular arrhythmias .
Effects of antiarrhythmic therapy . In view of the CAST findings (17) . the deleterious effects of antiarrhythmic agents on survival must be considered . In this study, there was no routine use of antiarrhythmic agents other than betablockers and no patient received empiric treatment with any antiarrhythmic agent at the time of discharge or before presentation with a clinical arrhythmia. For those patients who had a sustained ventricular arrhythmia during folioup, the normal practice was to initiate electrophysiologically guided drug therapy. To our knowledge, no arrhythmic death was precipitated by the proarrhythmic effects of drug therapy .
Cost-effectiveness and treatment options . The value of prognostic tests must be judged against the cost and benefits of treatment . The combination of heart rate variability, ambulatory ECU data and signal-averaged ECG data offers an inexpensive and simple method of risk stratification that is compatible with a number of treatment strategies. When simple low cost treatment options such as beta-hlocker therapy are considered, patients can be selected on the basis of either low heart rate variability or a positive signal-averaged ECG and the low specificity of each test is not a problem . However, if more expensive invasive strategies such as an automatic implantable defibrillator are to be used, a highly specific test that minimizes false positive results is needed and the choice of selection criteria will reflect this . Combinations such as heart rate variability, late potentials or heart rate variability, late potentials plus repetitive ventricular forms may be an appropriate method of selecting patients at high risk in whom such strategies could be tested.
Conclusions . Heart rate variability in combination with late potentials an the signal-averaged ECG or other Holler ECG variables provides a simple method of risk stratification that specifically identifies a small group of patients at high risk for arrhythmic events late after infarction . It is independent of left ventricular function, avoiding the need for a time-consuming and costly investigation, and the results are quickly available . Consequently, decisions regarding treat-FARRELI . P7 AL PRP.UICTIr7N OF ARRHYTHMICEVLNTS ment and further investigations can be made early before hospital discharge . In the near future, it is likely that an integrated ambulatory ECG system will be developed that will be capable of providing conventional data, heart rate variability and a signal-averaged ECG, thereby allowing risk stratification based on a single long-term ECG recording.
